Cargando…
Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis
PURPOSE: The prognostic value of neutrophil-to-lymphocyte ratio (NLR) has been studied for colorectal cancer. Elderly patients in general tend to have comorbidities and decreased organ function that potentially influence the NLR score. The aim of this study was to investigate the relationship betwee...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830562/ https://www.ncbi.nlm.nih.gov/pubmed/36636228 http://dx.doi.org/10.2147/CEG.S385207 |
_version_ | 1784867695507800064 |
---|---|
author | Tominaga, Tetsuro Nonaka, Takashi Oyama, Shosaburo Takamura, Yuma Hashimoto, Shintaro Shiraishi, Toshio Sawai, Terumitsu Nagayasu, Takeshi |
author_facet | Tominaga, Tetsuro Nonaka, Takashi Oyama, Shosaburo Takamura, Yuma Hashimoto, Shintaro Shiraishi, Toshio Sawai, Terumitsu Nagayasu, Takeshi |
author_sort | Tominaga, Tetsuro |
collection | PubMed |
description | PURPOSE: The prognostic value of neutrophil-to-lymphocyte ratio (NLR) has been studied for colorectal cancer. Elderly patients in general tend to have comorbidities and decreased organ function that potentially influence the NLR score. The aim of this study was to investigate the relationship between NLR and cancer-specific survival in elderly patients with colon cancer, using a propensity score-matched analysis. PATIENTS AND METHODS: A total of 203 patients aged over 75 years who underwent curative resection for colon cancer and were diagnosed pathologically with stage II/III disease were eligible for entry to the study. Patients were divided into two groups according to NLR score: NLR-High (NLR≥4.5) group (NLR-H, n=60) and NLR-Low (NLR<4.5) group (NLR-L, n=143). After propensity score matching, 57 patients in each group were matched. RESULTS: Before matching, Charlson comorbidity index was significantly higher in the NLR-H group (4 vs 2, p<0.001). After matching, all factors were similar between the groups. The median follow-up period was 43 months (range, 1–160 months). Five-year relapse-free-survival (69.8% vs 87.3%, p=0.030) and cancer-specific survival (83.0% vs 96.0%, p=0.042) were significantly lower in the NLR-H group. CONCLUSION: NLR appears to be a cancer-specific prognostic marker in elderly patients with colon cancer. |
format | Online Article Text |
id | pubmed-9830562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-98305622023-01-11 Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis Tominaga, Tetsuro Nonaka, Takashi Oyama, Shosaburo Takamura, Yuma Hashimoto, Shintaro Shiraishi, Toshio Sawai, Terumitsu Nagayasu, Takeshi Clin Exp Gastroenterol Original Research PURPOSE: The prognostic value of neutrophil-to-lymphocyte ratio (NLR) has been studied for colorectal cancer. Elderly patients in general tend to have comorbidities and decreased organ function that potentially influence the NLR score. The aim of this study was to investigate the relationship between NLR and cancer-specific survival in elderly patients with colon cancer, using a propensity score-matched analysis. PATIENTS AND METHODS: A total of 203 patients aged over 75 years who underwent curative resection for colon cancer and were diagnosed pathologically with stage II/III disease were eligible for entry to the study. Patients were divided into two groups according to NLR score: NLR-High (NLR≥4.5) group (NLR-H, n=60) and NLR-Low (NLR<4.5) group (NLR-L, n=143). After propensity score matching, 57 patients in each group were matched. RESULTS: Before matching, Charlson comorbidity index was significantly higher in the NLR-H group (4 vs 2, p<0.001). After matching, all factors were similar between the groups. The median follow-up period was 43 months (range, 1–160 months). Five-year relapse-free-survival (69.8% vs 87.3%, p=0.030) and cancer-specific survival (83.0% vs 96.0%, p=0.042) were significantly lower in the NLR-H group. CONCLUSION: NLR appears to be a cancer-specific prognostic marker in elderly patients with colon cancer. Dove 2023-01-05 /pmc/articles/PMC9830562/ /pubmed/36636228 http://dx.doi.org/10.2147/CEG.S385207 Text en © 2023 Tominaga et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Tominaga, Tetsuro Nonaka, Takashi Oyama, Shosaburo Takamura, Yuma Hashimoto, Shintaro Shiraishi, Toshio Sawai, Terumitsu Nagayasu, Takeshi Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis |
title | Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis |
title_full | Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis |
title_fullStr | Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis |
title_full_unstemmed | Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis |
title_short | Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis |
title_sort | efficacy of neutrophil-to-lymphocyte ratio for cancer-specific survival in elderly patients with localized colon cancer: a single center propensity score-matched analysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830562/ https://www.ncbi.nlm.nih.gov/pubmed/36636228 http://dx.doi.org/10.2147/CEG.S385207 |
work_keys_str_mv | AT tominagatetsuro efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis AT nonakatakashi efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis AT oyamashosaburo efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis AT takamurayuma efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis AT hashimotoshintaro efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis AT shiraishitoshio efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis AT sawaiterumitsu efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis AT nagayasutakeshi efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis |